C. R. Bard
Clinical trials sponsored by C. R. Bard, explained in plain language.
-
New device aims to simplify dialysis access for kidney patients
Disease control CompletedThis study tested a new device called FLEX-1 that creates a special blood vessel connection (arteriovenous fistula) for people with advanced kidney disease who need dialysis. Sixteen adults with stage 4 or 5 chronic kidney disease took part. The goal was to see if the device is s…
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 17, 2026 07:34 UTC
-
New device aims to improve dialysis access for kidney patients
Disease control CompletedThis study tested a new device called FLEX-1 to create a special blood vessel connection (arteriovenous fistula) for people with advanced chronic kidney disease who need dialysis. The study included 17 adults with stage 4 or 5 kidney disease. The goal was to see if the device was…
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 17, 2026 07:31 UTC
-
New device aims to simplify dialysis access for kidney patients
Disease control CompletedThis study tested a device called the everlinQ System in 32 adults with kidney failure who need hemodialysis. The device creates a connection between a vein and artery in the arm to allow easy blood flow for dialysis. The main goals were to see if the connection matures properly …
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Silver-coated tube shows promise in preventing fluid return in cancer patients
Disease control CompletedThis study tested a new catheter coated with silver nitrate against the standard PleurX catheter in 119 people with recurrent fluid buildup in the chest due to cancer. The goal was to see if the silver-coated version could seal the space and prevent fluid from coming back more ef…
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New Needle-Free access could ease dialysis for kidney patients
Disease control CompletedThis study tested a new device that creates a connection between an artery and vein using a needle instead of surgery, making dialysis access easier. It involved 24 adults with kidney failure who needed dialysis. The goal was to see if the device could successfully create this ac…
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New Needle-Free approach to dialysis access shows promise
Disease control CompletedThis study tested a new device called the FLEX System that creates a connection between an artery and a vein (AV fistula) using a small tube inserted through the skin, instead of surgery. The goal was to see if this method is safe and works well for people with chronic kidney dis…
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
Researchers check What's left in antiseptic dressings after a week
Knowledge-focused CompletedThis study looked at how much of the germ-killing ingredient chlorhexidine remains in special dressings after being worn for 7 days. It also checked for a breakdown product called PCA. Forty-five healthy adults wore the dressings, but the study did not test any treatment or cure …
Phase: PHASE1 • Sponsor: C. R. Bard • Aim: Knowledge-focused
Last updated May 17, 2026 07:37 UTC
-
Skin prep study shows bacteria busting power
Knowledge-focused CompletedThis study tested how well a skin cleaner called ChloraPrep One-Step kills bacteria on the skin before surgery. 27 healthy adults took part. Researchers measured the change in bacteria count 10 minutes after applying the cleaner. The goal was to see if it effectively reduces germ…
Phase: PHASE4 • Sponsor: C. R. Bard • Aim: Knowledge-focused
Last updated May 17, 2026 07:35 UTC
-
New study checks how well a skin cleaner kills germs before shots
Knowledge-focused CompletedThis study tested how well a skin disinfectant called ChloraPrep kills bacteria before injections. 25 healthy adults had the disinfectant applied to their skin, and researchers measured the number of bacteria before and after (at 30 seconds and 10 minutes). The goal was to see ho…
Phase: PHASE4 • Sponsor: C. R. Bard • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC